Cat. #162066
Anti-CD20 canine [NCD-1.2]
Cat. #: 162066
Sub-type: Primary antibody
Availability: 3-4 weeks
Target: canine CD20
Class: Monoclonal
Reactivity: Dog
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Moravian Biotechnology
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CD20 canine [NCD-1.2]
- Clone: NCD-1.2
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 33-37 kDa (based on literature)
- Reactivity: Dog
- Host: Mouse
- Description: Antibody created to detect canine CD20, epitope NCDPANP (the human NCEPANP is not recognised).
- Immunogen: NCDPANPSEKNSLSIQYCGSIR of canine CD20
- Isotype: IgG1 kappa
- Production details: B cell donor: Splenocytes from mouse immunised with peptide NCDPANPSEKNSLSIQYCGSIR. Fusion partner: SP2.
Target Details
- Target: canine CD20
- Molecular weight: 33-37 kDa (based on literature)
- Target background: CD20 is a transmembrane phosphoprotein that is expressed on the surface of malignant and normal B lymphocytes. As CD20 expression is restricted to B cells, this antigen is a useful marker or target for B-cell lymphomas. Studies demonstrate that the expression of CD20 correlates with B-cell lymphoma in dogs.
- Epitope sequence: NCDPANPSEKNSLSIQYCGSIR
Handling
- Format: Liquid
- Shipping conditions: Dry ice
References
- PMID: 33284343
